Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06194747 · ClinicalTrials.gov registry record · NA
Improving Status Epilepticus Treatment Times
A NA study of Status Epilepticus, sponsored by Nationwide Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 1
- Study location
NCT06194747: Recruiting NA study of Status Epilepticus, sponsored by Nationwide Children's Hospital.
NCT06194747 is a NA study of Status Epilepticus that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 450 participants, below the 2,788-participant average among 10 other Status Epilepticus trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06194747, a NA study of Status Epilepticus, is actively recruiting participants, sponsored by Nationwide Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a stepped-wedge cluster randomized effectiveness-implementation hybrid study aimed at determining the effect of dissemination of a QI bundle on the time to treatment of SE among hospitalized, non-critically ill children. The primary study endpoint is to decrease the time from the SE diagnosis to treatment with the first dose of a benzodiazepine (BZD) as measured during hospitalization, which will decrease chances of morbidity and mortality.
Primary Outcome
Time in minutes from SE diagnosis to treatment with the first dose of a benzodiazepine (BZD) as measured during hospitalization, which will decrease chances of morbidity and mortality
Conditions Studied
Interventions
- OTHER Quality improvement bundle
- OTHER Quality improvement bundle and local PDSA cycles with central support
- OTHER Quality improvement bundle and local PDSA cycles without central support
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT06194747 shows while recruiting
NCT06194747 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 2,788-participant average among 10 other Status Epilepticus trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Status Epilepticus appearing as the primary indexed condition, and to 3 interventions - of which Quality improvement bundle is the first listed.
NCT06194747 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06194747 about?
NCT06194747 is a clinical study titled "Improving Status Epilepticus Treatment Times". This is a stepped-wedge cluster randomized effectiveness-implementation hybrid study aimed at determining the effect of dissemination of a QI bundle on the time to treatment of SE among hospitalized, non-critically ill children. The primary study endpoint is to decrease the time from the SE diagnosi...
What is the current status of trial NCT06194747?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2024-02-01. Estimated completion is 2027-03-31.
What conditions does trial NCT06194747 study?
This clinical trial studies the following conditions: Status Epilepticus.
What interventions are being tested in trial NCT06194747?
The interventions under investigation include: Quality improvement bundle (OTHER), Quality improvement bundle and local PDSA cycles with central support (OTHER), Quality improvement bundle and local PDSA cycles without central support (OTHER).
Who is sponsoring clinical trial NCT06194747?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06194747 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Status Epilepticus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06194747's enrollment target sits among peer trials
450 6th of 10 higher than 5 of 10 other Status Epilepticus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Status Epilepticus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Simulation Trial of Telemedical Support for Paramedics
RECRUITING · NA
-
Seizure Rescue Medication: Caregiver Education in a Simulation Setting
COMPLETED · NA
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
Rapid-Response EEG in Children With Suspected Status Epilepticus
RECRUITING
-
Improving Outcomes for Patients With Life-Threatening Neurologic Illness
RECRUITING
-
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI